Department of Oral Maxillofacial Surgery, New York University College of Dentistry, 421 First Avenue, 233W, New York, NY 10010, USA.
J Dent Res. 2012 May;91(5):447-53. doi: 10.1177/0022034511424156. Epub 2011 Oct 4.
Cancer pain is an ever-present public health concern. With innovations in treatment, cancer patients are surviving longer, but uncontrollable pain creates a poor quality of life for these patients. Oral cancer is unique in that it causes intense pain at the primary site and significantly impairs speech, swallowing, and masticatory functions. We propose that oral cancer pain has underlying biologic mechanisms that are generated within the cancer microenvironment. A comprehensive understanding of key mediators that control cross-talk between the cancer and peripheral nervous system, and possible interventions, underlies effective cancer pain management. The purpose of this review is to explore the current studies on oral cancer pain and their implications in clinical management for cancer pain in general. Furthermore, we will explore the endogenous opioid systems and novel cancer pain therapeutics that target these systems, which could solve the issue of opiate tolerance and improve quality of life in oral cancer patients.
癌症疼痛是一个始终存在的公共卫生问题。随着治疗方法的创新,癌症患者的存活时间更长,但无法控制的疼痛给这些患者的生活质量带来了极大的影响。口腔癌的独特之处在于它会在原发部位引起剧烈疼痛,并严重影响言语、吞咽和咀嚼功能。我们提出,口腔癌疼痛的潜在生物学机制是在癌症微环境中产生的。全面了解控制癌症与外周神经系统之间相互作用的关键介质以及可能的干预措施,是有效管理癌症疼痛的基础。本文的目的是探讨目前关于口腔癌疼痛的研究及其对一般癌症疼痛临床管理的意义。此外,我们还将探讨内源性阿片肽系统和针对这些系统的新型癌症疼痛治疗药物,这可能解决阿片类药物耐受的问题,并提高口腔癌患者的生活质量。